KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Operating Leases (2019 - 2025)

Quest Diagnostics' Operating Leases history spans 7 years, with the latest figure at $732.0 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 0.97% year-over-year to $732.0 million; the TTM value through Dec 2025 reached $732.0 million, up 0.97%, while the annual FY2025 figure was $732.0 million, 0.97% up from the prior year.
  • Operating Leases for Q4 2025 was $732.0 million at Quest Diagnostics, up from $534.0 million in the prior quarter.
  • Across five years, Operating Leases topped out at $732.0 million in Q4 2025 and bottomed at $489.0 million in Q1 2024.
  • The 5-year median for Operating Leases is $507.5 million (2023), against an average of $546.6 million.
  • The largest annual shift saw Operating Leases fell 25.94% in 2021 before it surged 31.78% in 2022.
  • A 5-year view of Operating Leases shows it stood at $494.0 million in 2021, then soared by 31.78% to $651.0 million in 2022, then increased by 1.84% to $663.0 million in 2023, then increased by 9.35% to $725.0 million in 2024, then increased by 0.97% to $732.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Operating Leases are $732.0 million (Q4 2025), $534.0 million (Q3 2025), and $540.0 million (Q2 2025).